Literature DB >> 25374127

Cystic apocrine ductal carcinoma in situ with increased EGFR expression, trisomy 7, and associated focal invasion.

Shogo Tajima1, Michihiko Waki2, Hatsuko Nasu3, Yoshimi Ide4.   

Abstract

A 71-year-old woman was admitted to our hospital with a lump in her right breast. Mammography revealed an internal high-density mass in the lower right breast, which was larger than it was 2 years ago. Considering the findings from ultrasonography, computed tomography, and cytology, an intracystic carcinoma could not be ruled out. The patient underwent excisional biopsy, which revealed an apocrine ductal carcinoma in situ (ADCIS) with focal invasive apocrine carcinoma (IAC). The diagnosis was based on morphology and immunohistochemistry (IHC), which was negative for the estrogen and progesterone receptors, and positive for the androgen receptor. Expression of the human epidermal growth factor receptor 2 and the epidermal growth factor receptor (EGFR) received an immunohistochemical score of 2+. Trisomy of chromosome 7, including multiple CEP 7 and EGFR signals, was observed in ADCIS by fluorescence in situ hybridization (FISH). IAC exhibited similar results for IHC and FISH. This is the first reported case showing trisomy 7 resulting in EGFR copy number gain and increased EGFR expression in ADCIS.

Entities:  

Keywords:  Apocrine ductal carcinoma in situ; Chromosome 7; Epidermal growth factor receptor; Invasive apocrine carcinoma; Trisomy

Mesh:

Substances:

Year:  2014        PMID: 25374127     DOI: 10.1007/s00795-014-0091-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  21 in total

1.  Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.

Authors:  T Moriya; K Sakamoto; H Sasano; M Kawanaka; H Sonoo; T Manabe; J Ito
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

Review 2.  Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee.

Authors: 
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

3.  EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.

Authors:  Rohit Bhargava; William L Gerald; Allan R Li; Qiulu Pan; Priti Lal; Marc Ladanyi; Beiyun Chen
Journal:  Mod Pathol       Date:  2005-08       Impact factor: 7.842

4.  Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.

Authors:  Trine Tramm; Jee-Yeon Kim; Fattaneh A Tavassoli
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

5.  Cystic apocrine hyperplasia is the most common finding in MRI detected breast lesions.

Authors:  Paula S Ginter; Abbey J Winant; Syed A Hoda
Journal:  J Clin Pathol       Date:  2013-10-22       Impact factor: 3.411

6.  Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.

Authors:  Yutaka Tsutsumi
Journal:  Jpn J Clin Oncol       Date:  2012-03-26       Impact factor: 3.019

7.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

8.  Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.

Authors:  Nafis Shafizadeh; James P Grenert; Vaibhav Sahai; Sanjay Kakar
Journal:  Hum Pathol       Date:  2009-12-29       Impact factor: 3.466

9.  Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients.

Authors:  Kimihiro Tanaka; Shigeru Imoto; Noriaki Wada; Noriko Sakemura; Kahiro Hasebe
Journal:  Breast J       Date:  2008-01-31       Impact factor: 2.431

10.  Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.

Authors:  Dawn R Cochrane; Sebastián Bernales; Britta M Jacobsen; Diana M Cittelly; Erin N Howe; Nicholas C D'Amato; Nicole S Spoelstra; Susan M Edgerton; Annie Jean; Javier Guerrero; Francisco Gómez; Satyanarayana Medicherla; Iván E Alfaro; Emma McCullagh; Paul Jedlicka; Kathleen C Torkko; Ann D Thor; Anthony D Elias; Andrew A Protter; Jennifer K Richer
Journal:  Breast Cancer Res       Date:  2014-01-22       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.